| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/22/2011 | CN100998776B Traditional Chinese medicine effervescent tablets for inducing sweat, cleaning damp and harmonizing middle-jiao, and its preparing method |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964582 Methods of treating skin and mucosal tissue atrophy using compositions including tensioning polymers |
| 06/21/2011 | US7964579 Compositions and methods for topical delivery of oligonucleotides |
| 06/21/2011 | US7964218 Granular preparations for oral administration |
| 06/21/2011 | US7964217 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| 06/21/2011 | US7964216 Orally administering to a patient a spaced drug delivery system, wherein first therapeutically active agent is released immediately and second therapeutically active agent is released as a pulse at predetermined time after administration |
| 06/21/2011 | US7964215 Delayed release dosage form |
| 06/21/2011 | US7964214 Method and composition for hyperthermally treating cells in the eye with simultaneous imaging |
| 06/21/2011 | US7964213 Patch and production method thereof |
| 06/21/2011 | US7964212 Effervescent compositions comprising phosphonates and methods related thereto |
| 06/21/2011 | US7964189 Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women |
| 06/21/2011 | US7964182 Pharmaceutical compositions comprising phosphate-binding polymer |
| 06/21/2011 | US7963956 Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique |
| 06/21/2011 | US7963935 Microprojection array having a beneficial agent containing coating |
| 06/21/2011 | CA2635412C Agent for prophylaxis and treatment of asthenopia or pseudomyopia |
| 06/21/2011 | CA2602281C Gynecological drugs encapsulated in sodium alginate microspheres for use in embolotherapy |
| 06/21/2011 | CA2594174C External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| 06/21/2011 | CA2572729C Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 06/21/2011 | CA2546064C Percutaneous absorption type cerebral protective agent |
| 06/21/2011 | CA2523024C Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique |
| 06/21/2011 | CA2508250C Pharmaceutical product that aims to alleviate or cure the snoring of a moderate or severe snorer |
| 06/21/2011 | CA2499273C Inhalation compositions |
| 06/21/2011 | CA2497980C Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid |
| 06/21/2011 | CA2480223C A composition for treating gastric ulcer and a process for preparing the same |
| 06/21/2011 | CA2472188C Polymeric gel system for the controlled delivery of codrugs |
| 06/21/2011 | CA2471007C Medication delivery system and monitor |
| 06/21/2011 | CA2465641C Phenoxy amine compounds and compositions for delivering active agents |
| 06/21/2011 | CA2462537C Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 06/21/2011 | CA2458889C A process for preparing crystalline drug particles by means of precipitation |
| 06/21/2011 | CA2446429C Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies |
| 06/21/2011 | CA2430934C A method of producing sustained-release preparations of a bioactive substance using high-pressure gas |
| 06/21/2011 | CA2428745C Enrobed core |
| 06/21/2011 | CA2415159C Antimicrobial composition useful for the treatment of bovine mastitis |
| 06/21/2011 | CA2396796C Stabilized medicinal aerosol particulate formulations |
| 06/21/2011 | CA2396785C A medicinal aerosol formulation |
| 06/21/2011 | CA2396648C A medicinal aerosol formulation |
| 06/21/2011 | CA2370143C Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 06/21/2011 | CA2286177C Composition for gene transfer into cells |
| 06/21/2011 | CA2203857C Microparticles for delivery of nucleic acid |
| 06/21/2011 | CA2172392C Methods of inhibiting phagocytosis |
| 06/16/2011 | WO2011072224A1 Dark chocolate delivery system for a combination of dietary supplements and pharmaceuticals |
| 06/16/2011 | WO2011072208A1 Ph sensitive compounds in taste masking within oral thin film strips |
| 06/16/2011 | WO2011072133A1 Therapeutic compositions and methods for delivery of active agents cleavably linked to nanoparticles |
| 06/16/2011 | WO2011072103A2 Glycerine based jelly compositions |
| 06/16/2011 | WO2011072069A2 Gastric retentive pharmaceutical compositions for extended release of polypeptides |
| 06/16/2011 | WO2011071995A2 Compounds and methods of treating ocular disorders |
| 06/16/2011 | WO2011071970A2 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt) |
| 06/16/2011 | WO2011071904A2 Inhibiting bacterial infection and biofilm formation |
| 06/16/2011 | WO2011071877A2 Partial dip coating of dosage forms for modified release |
| 06/16/2011 | WO2011071684A1 Oral rehydration solutions comprising dextrose |
| 06/16/2011 | WO2011071620A1 Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
| 06/16/2011 | WO2011071417A1 Bactericidal sorbent material and method for producing same |
| 06/16/2011 | WO2011071400A1 Method and composition for preparing stable liquid formulations of paracetamol |
| 06/16/2011 | WO2011071376A1 Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding |
| 06/16/2011 | WO2011071365A1 Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding |
| 06/16/2011 | WO2011071194A1 SOLID DISPERSIONS CONTAINING 20-O-β-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL |
| 06/16/2011 | WO2011071139A1 Dry-coated orally disintegrating tablet |
| 06/16/2011 | WO2011070361A1 Process and product |
| 06/16/2011 | WO2011070318A2 Topical formulation |
| 06/16/2011 | WO2011070300A1 Stable fat-soluble active principle particles |
| 06/16/2011 | WO2011070168A1 Pharmaceutical composition for treating cutaneous burns |
| 06/16/2011 | WO2011070125A1 Mucoadhesive buccal tablets for the treatment of orofacial herpes |
| 06/16/2011 | WO2011069974A2 Polyurethane dispersions for sealing the teats of the mammary glands in milking animals |
| 06/16/2011 | WO2011069629A2 Pharmaceutical composition comprising oligopeptides |
| 06/16/2011 | WO2011069414A1 Injection solution and injection formulation of traditional chinese medicine volatile oil and preparation mehtod therof |
| 06/16/2011 | WO2011069336A1 Use of saturated amines compounds in manufacture of medicaments for mobilizing peripheral blood hematopoietic stem cell |
| 06/16/2011 | WO2011069326A1 Bilayer tablet comprising atenolol and amlodipine |
| 06/16/2011 | WO2011051968A3 Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof |
| 06/16/2011 | WO2011051967A3 Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof |
| 06/16/2011 | WO2011049629A3 Methods of making and using compositions comprising flavonoids |
| 06/16/2011 | WO2011048564A3 Orally disintegrating tablets of flurbiprofen |
| 06/16/2011 | WO2011048503A3 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 06/16/2011 | WO2011045774A3 Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof |
| 06/16/2011 | WO2011045769A3 Anti-misuse solid oral dosage form provided having a modified specific release profile |
| 06/16/2011 | WO2011031476A3 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation |
| 06/16/2011 | WO2011029028A9 Targeted delivery using tissue-specific peptidomimetic ligands |
| 06/16/2011 | WO2011019940A3 Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method for use |
| 06/16/2011 | WO2011017346A3 Fast-acting naproxen composition with reduced gastrointestinal effects |
| 06/16/2011 | WO2011017107A3 Microbubble assisted viral delivery |
| 06/16/2011 | WO2011012990A3 Improved pharmacokinetics of s-adenosylmethionine formulations |
| 06/16/2011 | WO2011011733A3 Factor replacement therapy |
| 06/16/2011 | WO2011009039A3 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 06/16/2011 | WO2011008298A3 Novel axomadol dosage forms |
| 06/16/2011 | WO2010151150A3 Formulations for vertebrate pest control |
| 06/16/2011 | WO2010149794A3 Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane) |
| 06/16/2011 | WO2010149169A3 Controlled release formulations |
| 06/16/2011 | WO2010148533A8 A pharmaceutical composition with the effect of treating diabetes |
| 06/16/2011 | WO2010125470A3 Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| 06/16/2011 | WO2010097243A3 Process for forming solid oral dosage forms of solifenacin and its pharmaceutically acceptable salts |
| 06/16/2011 | WO2010096886A3 Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof |
| 06/16/2011 | WO2010089617A3 Transdermal pharmaceutical preparations |
| 06/16/2011 | WO2010087964A3 Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof |
| 06/16/2011 | WO2010085609A3 Controlled release systems from polymer blends |
| 06/16/2011 | WO2010075065A3 Methods for enhancing the release and absorption of water insoluble active agents |
| 06/16/2011 | WO2009092571A3 Bubbles and method for producing and manipulating bubbles |
| 06/16/2011 | US20110144764 Bone graft material |
| 06/16/2011 | US20110144622 Methods, systems, and kits for implanting articles |
| 06/16/2011 | US20110144562 Localized Pharmacological Treatment of Ocular Tissue Using High-Intensity Pulsed Electrical Fields |
| 06/16/2011 | US20110144313 Membrane fusion proteins derived from reovirus |